Genome-wide analysis of wild-type epstein-barr virus genomes derived from healthy individuals of the 1000 genomes project

Genome Biology and Evolution

Volumn 6, Issue 4, 2014, Pages 846-860

  Santpere, Gabriel ^a   Darre, Fleur ^a   Blanco, Soledad ^b   Alcami, Antonio ^b   Villoslada, Pablo ^c   Albà, M Mar ^d,e   Navarro, Arcadi ^a,e,f  

^a CSIC   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^f CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

EBV; Human herpesvirus 4; Illumina reads; Recombination; Selection; Whole genome analysis

Indexed keywords

VIRUS PROTEIN;

CHROMOSOME MAP; EPSTEIN BARR VIRUS; FEMALE; GENETIC ASSOCIATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; MALE; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIRUS GENOME; VIRUS LATENCY;

BASE SEQUENCE; CHROMOSOME MAPPING; EVOLUTION, MOLECULAR; FEMALE; GENOME, VIRAL; GENOME-WIDE ASSOCIATION STUDY; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; VIRAL PROTEINS; VIRUS LATENCY;

EID: 84902995038     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evu054     Document Type: Article

References (73)

1. Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB. 1994. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol. 75(Pt 1):95-100.
2. Al-Mozaini M, et al. 2009. Epstein-Barr virus BART gene expression. J Gen Virol 90:307-316.
3. Anisimova M, Bielawski JP, Yang Z. 2001. Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol. 18:1585-15892.
4. Arvey A, et al. 2012. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe. 12:233-245.
5. Ascherio A, Munger KL. 2010. Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol. 5:271-277.
6. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
7. Baer R, et al. 1984. DNA sequence and expression of the B95-8 Epstein- Barr virus genome. Nature 310:207-211.
8. Borza CM, Hutt-Fletcher LM. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med. 8: 594-599.
9. Brennan RM, et al. 2010. Strains of Epstein-Barr virus infecting multiple sclerosis patients. Mult Scler. 16:643-651.
10. Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K. 2009. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res. 143:209-221.
11. Charif D, Lobry JR. 2007. Seqin{R} 1.0-2: a contributed package to the {R} project for statistical computing devoted to biological sequences retrieval and analysis. In: Bastolla U, PortoM, Roman HE, Vendruscolo M, editors. Structural approaches to sequence evolution: molecules, networks, populations. New York: Springer Verlag. p. 207-232.
12. Concha M, et al. 2012. Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. J Virol. 86:1458-1467.
13. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. 2011. Fusing structure and function: a structural view of the herpesvirus entrymachinery. Nat Rev Microbiol. 9:369-381.
14. Connors J, et al. 2009. Circos: an information aesthetic for comparative genomics. Genome Res. 19:1639-1645.
15. DePristo MA, et al. 2011. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43: 491-498.
16. Dolan A, Addison C, Gatherer D, Davison AJ, McGeoch DJ. 2006. The genome of Epstein-Barr virus type 2 strain AG876. Virology 350: 164-170.
17. Durbin RM, et al. 2010. A map of human genome variation from population- scale sequencing. Nature 467:1061-1073.
18. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N. 1999. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95.
19. Edwards RH, Sitki-green D, Moore DT, Raab-traub N. 2004. Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol. 78: 868-881.
20. Görzer I, Niesters HGM, Cornelissen JJ, Puchhammer-Stöckl E. 2006. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res. 118: 105-114.
21. Guindon S, et al. 2010. New algorithms and methods to estimate maximum- likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 59:307-321.
22. Gulley BML, et al. 1994. Epstein-Barr virus DNA is abundant and monoclonal in the reed-sternberg and cells of Hodgkin's disease: association with mixed cellularity subtype Hispanic American ethnicity. Blood 83: 1595-1602.
23. Gutiérrez MI, et al. 2000. Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from IV positive and HIV negative patients. Leuk Lymphoma. 37:425-429.
24. Gutiérrez MI, et al. 2002. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst. 94:1757-1763.
25. Habeshaw G, Yao QY, Bell AI,Morton D, Rickinson AB. 1999. Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol. 73:965-975.
26. Johannsen E, et al. 2004. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A. 101:16286-16291.
27. Johnstone IM. 2001. On the distribution of the largest eigenvalue in principal component analysis. Ann Stat. 29:295-327.
28. Koboldt DC, et al. 2009. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25: 2283-2285.
29. Kosiol C, et al. 2008. Patterns of positive selection in six Mammalian genomes. PLoS Genet. 4:e1000144.
30. Kunimoto M, Tamura S, Tabata T, Yoshie O. 1992. One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol. 73(Pt 2):455-461.
31. Kwok H, et al. 2012. Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS One 7:e36939.
32. Li H, Durbin R. 2010. Fast and accurate long-read alignmentwith Burrows- Wheeler transform. Bioinformatics 26:589-595.
33. Li H, et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079.
34. Lin Z, et al. 2013. Whole genome sequencing of the Akata and Mutu Epstein-Barr virus (EBV) strains. J Virol. 87:1172-1182.
35. Liu P, et al. 2011. Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol. 85: 11291-11299.
36. Lorenzetti MA, et al. 2010. EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants. J Med Virol. 82:1730-1738.
37. Lung MLI, Chang RS, Jones JH. 1988. Genetic polymorphism of natural Epstein-Barr virus isolates from infectious. J Virol. 62:3862-3866.
38. Martini M, et al. 2007. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infect. 54:298-306.
39. Maydt J, Lengauer T. 2006. Recco: recombination analysis using cost optimization. Bioinformatics 22:1064-1071.
40. McGeoch D, Davison AJ. 1999. Chapter 17-The molecular evolutionary history of the herpesviruses. In: Domingo E, Webster R, Holland J, editors. Origin and evolution of viruses. London: Academic Press. p. 441-465.
41. McGeoch DJ. 2001. Molecular evolution of the gamma-Herpesvirinae. Philos Trans R Soc Lond B Biol Sci. 356:421-435.
42. McGeoch DJ, Gatherer D. 2007. Lineage structures in the genome sequences of three Epstein-Barr virus strains. Virology 359:1-5.
43. McVean G. 2009. A genealogical interpretation of principal components analysis. PLoS Genet. 5:e1000686.
44. Midgley RS, Bell AI, Mcgeoch DJ, Rickinson AB. 2003. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol. 77:11517-11530.
45. Midgley RS, et al. 2000. Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J Virol. 74:1544-1548.
46. Nozawa M, Suzuki Y, Nei M. 2009. Reliabilities of identifying positive selection by the branch-site and the site-prediction methods. Proc Natl Acad Sci U S A. 106:6700-6705.
47. Pages H, Aboyoun P, Lawrence M. IRanges: infrastructure formanipulating intervals on sequences. R package version 1.4.2 [data unknown].
48. Patterson N, Price AL, Reich D. 2006. Population structure and eigenanalysis. PLoS Genet. 2:e190.
49. R Development Core Team. 2012. R: a language and environment for statistical computing. Available from: http://www.r-project.org/.
50. Ryan JL, et al. 2006. Clonal evolution of lymphoblastoid cell lines. Lab Invest. 86:1193-1200.
51. Santón A, et al. 2011. High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis. Mult Scler. 17: 1295-1300.
52. Sawada A, et al. 2011. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family. J Gen Virol. 92:1032-1043.
53. Skare J, Edson C, Farley J, Strominger JL. 1982. The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome. J Virol. 44:1088-1091.
54. Smit AFA, Hubley R, Green P. 1996-2010. RepeatMasker. Available from: http://repeatmasker.org.
55. Srivastava G, Wong KY, Chiang AKS, Lam KY, Tao Q. 2000. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 95: 2443-2445.
56. Sugden B, Mark W. 1977. Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol. 23:503-508.
57. Swofford DL. 2003. PAUP*: phylogenetic analysis using parsimony (*and other methods). Version 4. Sunderland (MA): Sinauer Associates.
58. Thorvaldsdóttir H, Robinson JT, Mesirov JP. 2013. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 14:178-192.
59. Tierney RJ, et al. 2006. Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J Infect Dis. 193: 287-297.
60. Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD. 2003. Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 77: 6546-6550.
61. Walling DM, Raab-Traub N. 1994. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol. 68:7909-7917.
62. Walling DM, et al. 1992. Coinfection with multiple strains of the Epstein- Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A. 89:6560-6564.
63. Walling DM, et al. 1999. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene. J Infect Dis. 179:763-774.
64. Wang F, Rivailler P, Rao P, Cho Y. 2001. Simian homologues of Epstein- Barr virus. Philos Trans R Soc Lond B Biol Sci. 356:489-497.
65. Wang X, Liu X, Jia Y, et al. 2010. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. J Gen Virol. 91:2564-2573.
66. Wang Y, Liu X, Xing X, et al. 2010. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res. 147:258-264.
67. Watterson GA. 1975. On the number of segregating sites in genetical models without recombination. Theor Popul Biol. 276: 256-276.
68. Wickham H. 2009. ggplot2: elegant graphics for data analysis. New York: Springer. Available from: http://had.co.nz/ggplot2/book.
69. Wu L, et al. 2009. Epstein-Barr virus LF2: an antagonist to type I interferon. J Virol. 83:1140-1146.
70. Yang Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol. 24:1586-1591.
71. Young KA, Herbert AP, Barlow PN, Holers VM, Hannan JP. 2008. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350. J Virol. 82:11217-11227.
72. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 4:757-768.
73. Zeng M-S, et al. 2005. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol. 79: 15323-15330. Enfermedades Raras Raras